Nassir Medical Corporation

Nassir Medical Corporation was paid $2.39M by Medicaid between Jan 2018 and Nov 2024, across 53 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 25% of everything it billed.

33Billing provider infoNASSIR MEDICAL CORPORATION
LOS ANGELES, CA 90036

33aNPI1528150562assigned 09/28/2006

33bProvider typeHematology & Oncology Physician

28Total paid$2.39M

24GClaims260,400

24DCodes billed53

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Hematology & Oncology Physician providers in California

Rank by total paid#11 of 180

Median peer was paid$26K

This provider vs. median93×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	40,741	$388K
2019	41,644	$356K
2020	31,230	$242K
2021	29,686	$333K
2022	35,670	$420K
2023	41,153	$389K
2024incomplete	40,276	$258K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	25%	13,179	7,415	$585K
96367		14%	18,778	4,791	$326K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	13%	14,039	4,610	$306K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	11%	8,980	3,685	$262K
96361	Intravenous infusion, hydration; each additional hour	10%	22,531	6,644	$240K
99233	Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m	6.7%	9,926	1,168	$159K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	3.4%	3,487	1,868	$81K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	3.1%	1,593	1,358	$74K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	2.4%	24,418	6,847	$57K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.0%	19,746	7,757	$47K
J2405	Injection, ondansetron hydrochloride, per 1 mg	1.9%	20,870	5,102	$45K
99000		1.2%	8,783	3,658	$28K

41 more codes

96375	Therapeutic injection; each additional sequential IV push	1.1%	1,687	$27K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	3,588	$23K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,115	$22K
80048	Basic metabolic panel (calcium, ionized)	<1%	14,030	$22K
96415		<1%	717	$12K
80076		<1%	10,949	$12K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	3,671	$11K
J3490	Unclassified drugs	<1%	10,047	$7K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,675	$6K
96417		<1%	264	$4K
82378		<1%	1,640	$4K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	849	$4K
99222	Initial hospital care, per day, moderate complexity	<1%	313	$4K
36415	Collection of venous blood by venipuncture	<1%	7,372	$3K
84443	Thyroid stimulating hormone (TSH)	<1%	1,369	$3K
G9903	Patient screened for tobacco use and identified as a tobacco non-user	<1%	5,847	$2K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	124	$1K
99232	Hospital visit by a doctor, follow-up day	<1%	80	$1K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	99	$1K
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	<1%	6,652	$840.21
J2780	Injection, ranitidine hydrochloride, 25 mg	<1%	77	$837.38
80061	Lipid panel	<1%	445	$784.17
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	4,843	$698.06
1036F		<1%	3,534	$648.47
J2270	Injection, morphine sulfate, up to 10 mg	<1%	121	$645.34
99205	Prolong outpt/office vis	<1%	14	$642.00
G8420	Bmi is documented within normal parameters and no follow-up plan is required	<1%	4,247	$568.78
J1170	Injection, hydromorphone, up to 4 mg	<1%	88	$409.51
G8731	Pain assessment using a standardized tool is documented as negative, no follow-up plan required	<1%	2,559	$355.56
G9991	Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period	<1%	839	$350.76
84153		<1%	216	$311.02
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	166	$216.59
3017F		<1%	659	$131.36
1123F		<1%	1,073	$37.14
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	<1%	1,289	$27.63
84403		<1%	14	$25.81
G8482	Influenza immunization administered or previously received	0%	416	$0.00
G8730	Pain assessment documented as positive using a standardized tool and a follow-up plan is documented	0%	981	$0.00
G9899	Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed	0%	165	$0.00
4040F		0%	222	$0.00
1124F		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNASSIR, YOURAM (CEO)